Apixaban in Subclinical Atrial Fibrillation | NEJM

Subclinical atrial fibrillation is associated with increased stroke risk, but it is unclear whether oral anticoagulation could lower this risk.
New research findings are summarized in a short video.
To see the full article, follow this link: nej.md/3sqCbJ1

[@geoffcutter1617]

The Apixaban dose for AF prophylaxis is currently 20mg daily-double the dose in this trial which used a recognised aspirin dose .

[@drahmedelshammaa7711]

What are the recommendations of this trial?